Global Information
회사소개 | 문의 | 비교리스트

세계의 수화물 저해제 시장 : 규모, 점유율, 동향, 예측(2022-2028년)

Hydrate Inhibitor Market - Size, Share, trends, and Forecast, 2022 - 2028

리서치사 Coherent Market Insights
발행일 2022년 05월 상품코드 1084481
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,500 ₩ 6,392,000 PDF (Single User License)
US $ 7,000 ₩ 9,944,000 PDF (Multi User License)
US $ 10,000 ₩ 14,206,000 PDF (Enterprise User License)


세계의 수화물 저해제 시장 : 규모, 점유율, 동향, 예측(2022-2028년) Hydrate Inhibitor Market - Size, Share, trends, and Forecast, 2022 - 2028
발행일 : 2022년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 수화물 저해제 시장 규모는 천연가스와 석유의 수요 증가 등에 의해 촉진되고 있습니다.

세계의 수화물 저해제 시장을 조사했으며, 시장의 개요, 시장 규모 및 예측, 동향, 성장요인, 억제요인, 저해제 유형·지역별 분석 및 경쟁 구도 등을 정리하여 전해드립니다.

목차

제1장 조사 목적·전제조건

  • 조사 목적
  • 가정
  • 약어

제2장 시장의 전망

  • 리포트 설명
    • 시장의 정의와 범위
  • 개요
    • 시장 내역 : 저해제 유형별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제 및 동향 분석

  • 시장 역학
    • 촉진요인
    • 공급측의 성장요인
    • 수요측의 성장요인
    • 경제적 추진력
    • 억제요인
    • 시장 기회
    • 규제 시나리오
    • 업계 동향
    • 합병과 인수
    • 신제품 승인/발매
    • 프로모션 및 마케팅 구상
  • 비용 Tier Down 분석

제4장 세계의 수화물 저해제 시장 : 저해제 유형별(2017-2028년)

  • 서론
  • 열역학적 저해제
  • 저용량 수화물 저해제(LDHI)
  • 하이브리드

제5장 세계의 수화물 저해제 시장 : 지역별(2017-2028년)

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동
  • 아프리카

제6장 경쟁 구도

  • 히트맵 분석
  • 시장 점유율 분석(3x3 매트릭스)
  • 기업 개요
    • Halliburton
    • Ashland Global Specialty Chemicals Inc.
    • Ecolab Inc.
    • Baker Hughes Inc.
    • Innospec Inc.
    • JSC Gazprom Neftekhim Salavat
    • BASF SE
    • Evonik Industries Ag
    • Clariant AG
    • GasHydrate LLC
    • Schlumberger Limited
  • 애널리스트의 견해

제7장 섹션

KSA 22.06.20

Hydrate inhibitors are used to prevent or reduce gas hydrate formation. Gas hydrates are formed in offshore production systems under low temperature and high pressure conditions. These hydrates block pipelines, drill strings, BOP’s, by forming plugs, and cause flow assurance issues. Hydrate inhibitors are used where mechanical methods such as insulated flow line and active heating are not feasible options. However, political instability and low price of oil is a major factor negatively affecting growth of the global hydrate inhibitors market.

Market Dynamics

Increasing demand for natural gas and oil is expected to boost the global hydrate inhibitors market growth. Global demand for energy is increasing rapidly. Moreover, world natural gas consumption is expected to increase by 43% from 2015 to 2040 according to the International Energy Outlook 2021, as natural gas continues to be the fuel for electric power generation and for application in industrial sectors. Electric power and industrial sector uses around 75% of the natural gas of the projected increase in total consumption between 2015 and 2040.

By region, North America held a major market share of 58% in 2021. Middle East and Europe held significant market share in the global hydrate inhibitors market.

Europe is a lucrative market for hydrate inhibitors with significant demand due to high offshore oil production from the region in 2021 and it is expected to increase during forecast period. For instance, according to the EU, 567 million barrels of offshore oil had been produced in the U.K. in 2012. Furthermore, 95 million barrels of offshore oil and 105 million barrels of offshore gas production was recorded in Norway in 2012, according to the EU.

Key features of the study:

This report provides in-depth analysis of hydrate inhibitors market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global hydrate inhibitors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Key companies covered as a part of this study includes Halliburton, Ashland Global Specialty Chemicals Inc., Ecolab Inc., Baker Hughes Inc., Innospec Inc., JSC Gazprom Neftekhim Salavat, BASF SE, Evonik Industries AG, Clariant AG, GasHydrate LLC, and Schlumberger Limited.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics

The global hydrate inhibitors market report caters to various stakeholders in this industry including investors, suppliers, hydrate inhibitors manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the hydrate inhibitors market

Detailed Segmentation:

Global Hydrate Inhibitors Market, By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Global Hydrate Inhibitors Market, By Geography:

North America

U.S.

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Canada

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Europe

U.K.

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Germany

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

France

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Italy

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Spain

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Russia

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Rest of Europe

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Asia Pacific

China

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

India

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Japan

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

ASEAN

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Australia

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

South Korea

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Rest of Asia Pacific

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Latin America

Brazil

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Argentina

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Mexico

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Rest of Latin America

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Middle East

GCC

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Israel

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Rest of Middle East

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Africa

Northern Africa

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Central Africa

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

South Africa

By Inhibitor Type:

Thermodynamic Inhibitors

Methanol

Mono Ethylene Glycol (MEG)

Low Dosage Hydrate Inhibitors (LDHI’s)

Anti-Agglomeration Inhibitors/Surfactants

Quaternary Ammonium Compounds

Amides

Bio-surfactants

Kinetic Inhibitors

Polyvinylcaprolactam

Polyvinylpyrrolidone

Polyethyloxazoline

N-methyl-N-vinylacetamide

Tetra pentyl ammonium bromide

Butoxy-ethanol

Emulsifiers

Hybrid

Company Profiles

Halliburton*

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Future Plans

Ashland Global Specialty Chemicals Inc.

Ecolab Inc.

Baker Hughes Inc.

Innospec Inc.

JSC Gazprom Neftekhim Salavat

BASF SE

Evonik Industries AG

Clariant AG

GasHydrate LLC

Schlumberger Limited

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Inhibitor Type
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Supply Side Drivers
    • Demand Side Drivers
    • Economic Drivers
    • Restraints
    • Market Opportunities
    • Regulatory Scenario
    • Industry Trend
    • Merger and Acquisitions
    • New Product Approvals/Launch
    • Promotion and Marketing Initiatives
  • Cost Tier Down Analysis

4. Global Hydrate Inhibitors Market, By Inhibitor Type, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Thermodynamic Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Low Dosage Hydrate Inhibitors (LDHI's)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Hybrid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Hydrate Inhibitors Market, By Region, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • U.S.
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Canada
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
  • Europe
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • U.K.
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Germany
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • France
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Italy
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Spain
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Russia
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Rest of Europe
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
  • Asia Pacific
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • China
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • India
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Japan
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • ASEAN
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Australia
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • South Korea
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Rest of Asia Pacific
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
  • Latin America
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • Brazil
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Argentina
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Mexico
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Rest of Latin America
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
  • Middle East
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • GCC
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Israel
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Rest of Middle East
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
  • Africa
    • Market Share Analysis, By Country, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Country, 2017 - 2028
    • Northern Africa
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • Central Africa
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)
    • South Africa
    • Country Trends
    • Market Size and Forecast, By Inhibitor Type, 2017 - 2028 (US$ Million)

6. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • Halliburton
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Ashland Global Specialty Chemicals Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Ecolab Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Baker Hughes Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Innospec Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • JSC Gazprom Neftekhim Salavat
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • BASF SE
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Evonik Industries Ag
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Clariant AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • GasHydrate LLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
    • Schlumberger Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Future Plans
  • Analyst Views

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact
  • Browse 150 market data tables* and 90 figures* on "Hydrate Inhibitors Market" - Global forecast to 2028.
Back to Top
전화 문의
F A Q